Liver Fibroses Clinical Trials
3 recruiting trials for Liver Fibroses. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Liver Fibroses clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Manchester University NHS Foundation Trust (1), University of Roma La Sapienza (1), Sherief Abd-Elsalam (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Blood tests for Single Nucleotide Polymorphisms (other, 1 trial), followed by Faecal microbiome analysis, Serum for diagnostic biomarkers.
Track Liver Fibroses trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Integrated Diagnostics for Early Diagnosis of Liver Disease
This is an observational study that will explore the hypothesis that by combining data from patients with liver disease with novel blood biomarkers, single nucleotide polymorphism...
Liver Damage and Cardiometabolic Disorders in NAFLD
Liver fibrosis is the most important prognostic factor in patients with non-alcoholic factor disease. Clinical and biological condition, as diabetes or mutation for PNPLA3, are...
Effect of Some Drugs on Liver Fibrosis
Effect of Some Drugs on Liver Fibrosis
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Liver Fibroses, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Liver Fibroses, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Liver Fibroses, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.